Honggang Zhang

ORCID: 0009-0000-1034-4067
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vascular Procedures and Complications
  • Bone fractures and treatments
  • Elbow and Forearm Trauma Treatment
  • Ferroptosis and cancer prognosis
  • Orthopedic Surgery and Rehabilitation
  • Cancer-related molecular mechanisms research
  • Inflammatory Biomarkers in Disease Prognosis
  • Central Venous Catheters and Hemodialysis
  • Venous Thromboembolism Diagnosis and Management

Kangda College of Nanjing Medical University
2025

Nanjing Medical University
2025

Xuzhou Medical College
2025

The First People’s Hospital of Lianyungang
2023-2025

Endothelial progenitor cells (EPCs) provide a promising therapeutic choice for deep venous thrombosis (DVT). Their number is increased by epigallocatechin-3-gallate (EGCG) in patients with diabetes. Although EGCG effective against doxorubicin-induced ferroptosis and cardiotoxicity, its efficacy DVT treatment has not been well studied. This study was aimed at assessing the effects of on EPC recanalization model. EPCs were treated EGCG, their proliferation migration, angiogenesis, apoptosis...

10.1002/ptr.8457 article EN Phytotherapy Research 2025-02-07

Objective To evaluate the clinical efficacy and safety of novel ZelanteDVT™ catheter rheolytic thrombectomy in single-session endovascular management subacute deep venous thrombosis (DVT). Methods A retrospective study was performed on 31 patients with DVT who underwent thrombectomy. Procedure data, associated complications, patency score were recorded. The post-thrombotic syndrome (PTS) rate assessed all during follow-up visits. Results After procedure, 19.4% (6/31) improved to grade III...

10.1177/02683555231188900 article EN Phlebology The Journal of Venous Disease 2023-07-12
Coming Soon ...